Rank #1491PTGX

Protagonist Therapeutics, Inc.

$83.09

0.12% (Daily)

Market Cap

$5.19B

Revenue

$209.22M

Rank by MCap

#1491

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Dinesh V. Patel Ph.D.

Headquarters

Newark, CA

Employees

128

About Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide, an injectable mimetic of hepcidin that is in phase 3 clinical trials for the treatment of polycythemia vera; Icotrokinra, an orally delivered investigational drug which is in phase 3 clinical trials indicated to block biological pathways targeted by marketed injectable antibody drugs; and PN-...